Neupogen
Links shared publicly online about this topic
Neupogen - Page 2 - Nursing for Nurses
allnurses.com — “IDK if this matters or not- BUT I got Neupogen (or Neulasta) only on the weekends, since I had to resume chemo on Mondays. The doc wanted the Neupogen” View full resource at allnurses.com
Most Recently Shared on November 9, 2011 at 12:27 am By:
Neupogen: Hi, I am an new RN and just got hired into a chemotherapy clinic. First off, it is sink or... http://t.co/hmgIsT89
FDA to assess Neupogen biosimilar | InPharm
inpharm.com — “FDA to assess Neupogen biosimilar | InPharm” View full resource at inpharm.com
Most Recently Shared on February 3, 2010 at 11:45 am By:
Pharmafocus Health News and Pharma
FDA to assess Neupogen biosimilar. Developed by Teva it would be marketed by Hospira. http://ow.ly/13kjp
Teva to seek U.S. approval for Neupogen biosimilar | Reuters
reuters.com — “By Lewis Krauskopf NEW YORK, Feb 18 (Reuters) - Teva Pharmaceutical Industries Ltd hopes to seek U.S. approval for its version of Amgen Inc's Neupogen this year, company” View full resource at reuters.com
Most Recently Shared on February 19, 2009 at 6:11 pm By:
eyeonfda Pharma and Health Lawyer
Reuters reports that Teva is to seek U.S. FDA approval this year for Neupogen biosimilar - http://is.gd/k8cF
UPDATE 1-FDA to review Teva biosimilar of Amgen's Neupogen | Reuters
reuters.com — “* FDA accepts filing of biosimilar to be called Neutroval * Teva shares up 1.4 pct, Amgen shares off slightly NEW YORK, Feb 2 (Reuters) - Generic drugmaker TevaPharmaceutical Industries Ltd” View full resource at reuters.com
Most Recently Shared on February 2, 2010 at 5:05 pm By:
Reuters: FDA to review Teva biosimilar of Amgen's Neupogen. http://bit.ly/9jmK6Y
Hospira gains EMA OK for Neupogen biosimilar - FierceBiotech
fiercebiotech.com — “Hospira says that it won European approval for its follow-on therapy to Amgen's blockbuster Neupogen. In winning the OK, Hospira provided late-stage data demonstrating that its therapy, Nivestim Read more...” View full resource at fiercebiotech.com
Most Recently Shared on June 10, 2010 at 4:32 pm By:
Hospira gains EMA OK for Neupogen biosimilar. http://bit.ly/adeduG
Copying biotech medicine attracts more drugmakers | Reuters
reuters.com — “* Branded makers consider entering biosimilars arena* Amgen, Biogen exploring biosimilars* Merck has Neupogen, Neulasta biosimilar trials underwayBy Deena BeasleySAN FRANCISCO, Jan 13 (Reuters)” View full resource at reuters.com
Most Recently Shared on January 18, 2011 at 2:22 pm By:
ScienceintheTriangle Science Enthusiast
More drugmakers consider making cheaper copies of biologic medicines. (Reuters) http://reut.rs/h5m4hR #SITT
Pegfilgrastim to accelerate neutrophil engraftment... [Leuk Lymphoma. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 18, 2011 at 11:47 pm By:
Robert Z. Orlowski Physician, Doctor, and Internist
Neulasta helps myeloma patients recover neutrophils more quickly after stem cell transplantation that Neupogen (http://bit.ly/fxOwho).
A randomized clinical trial comparing granulocyte-... [Transfusion. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 23, 2011 at 1:37 pm By:
Robert Z. Orlowski Physician, Doctor, and Internist
Location of injection site for Neupogen does not impact on the number of stem cells mobilized for transplantation (http://bit.ly/f652Wz).
FDA Seeks More Data on Teva Copy of Amgen Drug - WSJ.com
online.wsj.com — “The FDA declined to approve Teva's application to sell a copycat version of Amgen's Neupogen.” View full resource at online.wsj.com
Most Recently Shared on September 30, 2010 at 5:56 pm By:
FDA Seeks More Data on Teva Copy of Amgen Drug http://on.wsj.com/99CFtr
FDA Seeks More Data on Teva Copy of Amgen Drug - WSJ.com
online.wsj.com — “The FDA declined to approve Teva's application to sell a copycat version of Amgen's Neupogen.” View full resource at online.wsj.com
Most Recently Shared on September 30, 2010 at 8:05 pm By:
Scott Strumello Patient Expert
WSJ.com: "FDA Seeks More Data on Teva Copy of Amgen Drug" http://bit.ly/a821ku What, if anything, does this mean for follow-on insulin?
Copying biotech medicine attracts more drugmakers | Reuters
uk.reuters.com — “* Branded makers consider entering biosimilars arena * Amgen, Biogen exploring biosimilars * Merck has Neupogen, Neulasta biosimilar trials underway By Deena Beasley SAN FRANCISCO, Jan 13 (Reuters)” View full resource at uk.reuters.com
Most Recently Shared on January 14, 2011 at 2:02 pm By:
John Carroll Health Communicator
Now Biogen Idec says that it wants to get into biosimilars. Joins with Merck/Amgen. Every major player is getting in. http://reut.rs/gqXf2X
Cancer Blog - Greg's Cancer Blog: 4 Weeks out of Radiation and Chemo
greg.blogforacure.com — “I had a 4-week follow-up visit with my oncologist on Friday, February 26. Blood counts are still low. Some are lower than they were four weeks ago. They gave me an injection of Neupogen. That's a drug given to stimulate production of blood cells. Was given three other injections of Neupogen at times during chemotherapy. Normal white blood cell count should be 4.5 to 11.0. Mine is 1.0. That means I” View full resource at greg.blogforacure.com
Most Recently Shared on February 28, 2010 at 6:32 pm By:
4 Weeks out of Radiation and Chemo: Four weeks out of radiation and chemo and my blood counts are lower now than f... http://bit.ly/b9rbBT
Cancer Blog - jeanee's Cancer Blog: Treatment # 3 postponed
jeanee.blogforacure.com — “Hi all, I had an appointment yesterday to get treatment # 3 but they said no go after my WBC showed almost none. I think it was a 1.2. So I am now giving myself shots of neupogen and will try again on Monday. I was kinda bummed because it throws off my plans so to speak and I am also feeling really achey. I know they say that if you want to make God laugh you should tell him your plans haha. Ha” View full resource at jeanee.blogforacure.com
Most Recently Shared on February 25, 2010 at 10:08 pm By:
Treatment # 3 postponed: Hi all, I had an appointment yesterday to get treatment # 3 but they said no go after my... http://bit.ly/9Qtm88
Summary Box: Amgen profit falls in 3Q
health.yahoo.net — “FLAT VICTORY: Biotech drugmaker Amgen Inc. said Monday its third-quarter profit fell because of flat sales and higher operating costs, although the drugmaker still beat expectations.” View full resource at health.yahoo.net
Most Recently Shared on October 25, 2010 at 10:41 pm By:
Summary Box: Amgen profit falls in 3Q http://bit.ly/9aYQ0z
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
medicalnewstoday.com — “Teva pharmaceutical industries ltd. (nasdaq: teva), announced the submission of a biologics license application (bla) with the u.s. food and drug administration (fda) for xm02, a granulocyte colon” View full resource at medicalnewstoday.com
Most Recently Shared on December 3, 2009 at 6:24 am By:
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-I... http://bit.ly/5PDmeS
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
allnurses.com
Nursing Community with over 416,000 nurses connecting with other nurses each month @ allnurses.com are you?
-
Pharmafocus
Monthly pharmaceutical, biotech & healthcare news publication for Europe. For pharma & biotech jobs follow @inpharmjobs. Twitter accounts run by @dominic_tyer
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
Advertisement
